Benzodiazepines and Zolpidem for Chronic Insomnia
JAMAPublished 24 December 1997
Peter D. Nowell
Citations451
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Benzodiazepines and zolpidem produced reliable improvements in commonly measured parameters of sleep in patients with chronic insomnia, and presented challenges for developing evidence-based guidelines for the use of hypnotics in the management of chronic insomnia.
Abstract
Benzodiazepines and zolpidem produced reliable improvements in commonly measured parameters of sleep in patients with chronic insomnia. Relative to the chronic and recurring course of insomnia, both the limited duration of treatments studied and the lack of follow-up data from controlled trials represent challenges for developing evidence-based guidelines for the use of hypnotics in the management of chronic insomnia.
Keywords
PsychologySocial SciencesNeuroscience
Computers Environment and Urban SystemsStatistical power analysis for the behavioral sciences
65,645 Citations1990
Journal of Educational StatisticsStatistical Methods for Meta-Analysis
10,479 Citations1988Stanley Wasserman, Larry V. Hedges +1 more
JAMAEpidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?
2,453 Citations1989Daniel E. Ford
JAMAEpidemiologic Study of Sleep Disturbances and Psychiatric Disorders
2,251 Citations1989Daniel E. Ford
As part of the National Institute of Mental Health Epidemiologic Catchment Area study, 7954 respondents were questioned at baseline and 1 year later about sleep complaints and psychiatric symptoms using the Diagnostic Interview Schedule.
Journal of Educational StatisticsA Fail-Safe N for Effect Size in Meta-Analysis
1,729 Citations1983Robert G. Orwin
Academy of Management ReviewMeta-Analysis: Cumulating Research Findings across Studies
1,216 Citations1984Jack M. Feldman, John E. Hunter +2 more
American Journal of PsychiatryNonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy
1,106 Citations1994Charles M. Morin, J P Culbert +1 more
Stimulus control and sleep restriction were the most effective single therapy procedures, whereas sleep hygiene education was not effective when used alone.
Archives of General PsychiatryInsomnia and Its Treatment
1,065 Citations1985Glen D. Mellinger
The survey found that insomnia afflicts 35% of all adults during the course of a year; about half of these persons experience the problem as serious; the majority of serious insomniacs were untreated by either prescribed or over-the-counter medications.
Medical Entomology and ZoologyMeta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine
876 Citations1994Diana B. Petitti
American Journal of PsychiatrySelf-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia
554 Citations1976Mary A. Carskadon, William C. Dement +4 more
The authors compared the sleep laboratory recordings of 122 drug-free subjects who complained of chronic insomnia with the subjects' estimates of their habitual sleep characteristics and their estimated sleep time on the morning after sleeping in the laboratory, finding that most subjects consistently underestimated the amount of time they slept and overestimated the time it took them to get to sleep.
Journal of Educational StatisticsA Fail-Safe <i>N</i> for Effect Size in Meta-Analysis
551 Citations1983Robert G. Orwin
Journal of Consulting and Clinical PsychologyIdentifying effective psychological treatments for insomnia: A meta-analysis.
522 Citations1995Douglas Murtagh, Kenneth M. Greenwood
It is indicated that psychological treatments produce considerable enhancement of both sleep patterns and the subjective experience of sleep, in terms of enhancing sleep onset.
GutNon-colonic features of irritable bowel syndrome.
471 Citations1986Peter J. Whorwell, May F. McCallum +2 more
A wide variety of non-gastrointestinal symptoms were significantly more common than in a group of 100 age, sex, and social class matched controls and may be indicative of a much more diffuse disorder of smooth muscle than has previously been appreciated.
PubMedEconomic effects of insomnia.
323 Citations1995M K Stoller
The literature on the economic costs and effects associated with insomnia was reviewed and a conservative estimate of the total annual cost of insomnia was calculated at $92.5 to $107.5 billion.
Archives of General PsychiatryRecorded and Reported Sleep in Chronic Primary Insomnia
303 Citations1976Bernard L. Frankel
Perceptual and Motor SkillsThe Subjective Meaning of Good Sleep, An Intraindividual Approach Using the Karolinska Sleep Diary
298 Citations1994Torbjörn Åkerstedt, Ken Hume +2 more
It was concluded that most subjective sleep measures tend to covary across conditions and that “good sleep” is mainly a question of sleep continuity.
New England Journal of MedicineManagement of Insomnia
288 Citations1997David J. Kupfer, Charles F. Reynolds
This review focuses on the practical management of insomnia in adults and on the scientific basis of current treatments, which show that older men have more disrupted sleep.
SLEEPClinical Diagnoses in 216 Insomnia Patients Using the International Classification of Sleep Disorders (ICSD), DSM-IV and ICD-10 Categories: A Report From the APA/NIMH DSM-IV Field Trial
275 Citations1994Daniel J. Buysse, Charles F. Reynolds +10 more
Examination of clinical sleep disorder diagnoses in 257 patients found substantial site-related differences in diagnostic patterns, confirming the importance of psychiatric and behavioral factors in clinicians' assessments of insomnia patients across all three diagnostic systems.
PubMedSomatic diseases and sleep complaints. An epidemiological study of 3,201 Swedish men.
271 Citations1987Þórarinn Gíslason, Magnus Almqvist
PubMedPharmacology of benzodiazepine hypnotics.
241 Citations1992David J. Greenblatt
The "revolution" in pharmacologic treatment of insomnia began in 1970 with the availability of flurazepam, the first of the benzodiazepine hypnotics, which largely replaced all other hypnotics during the decade of the 1970s.
PubMedA multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
223 Citations1994Martin B. Scharf, Thomas Röth +2 more
10 mg of zolpidem was found to be safe and effective for the long-term treatment of chronic insomnia, demonstrating hypnotic efficacy without affecting sleep stages or producing tolerance effects, rebound effects, or detrimental effects on psychomotor performance.
European Archives of Psychiatry and Clinical NeuroscienceThe Zurich study
197 Citations1989Margarete Vollrath, Werner Wicki +1 more
Findings support the subdivision of insomnia into different subtypes and showed that insomnia tends to reoccur, and for subjects with insomnia either at age 21 or 23 years, there was a higher risk of further insomnia at follow-ups.
PsychopharmacologyCurrent benzodiazepine issues
195 Citations1995James H. Woods, Gail Winger
Reviews of epidemiological, clinical and experimental literature indicated that the previous conclusion about abuse of these drugs still holds: the vast majority of the use of benzodiazepines is appropriate.
SLEEPPersistent Psychophysiologic (Learned) Insomnia
179 Citations1986Peter Hauri, Joan M. Fisher
PPI patients and Ns revealed less psychopathology than DD patients on almost all psychological scales, and PPIs typically had difficulties initiating and maintaining sleep, as did the DDs, but showed normal sleep staging.
Psychosomatic MedicineBiopsychobehavioral Correlates of Insomnia. II. Pattern Specificity and Consistency with the Minnesota Multiphasic Personality Inventory
169 Citations1983Anthony Kales, Alex B. Caldwell +3 more
The results of this study confirm the original hypothesis that the handling of stresses and conflicts through an internalization of emotions leads to physiologic activation and is a major factor underlying the development and maintenance of chronic insomnia.
Psychiatry ResearchThe experience of insomnia and daytime and nightime functioning
165 Citations1984Wallace B. Mendelson, Debra Garnett +2 more
Ten insomniacs and matched control subjects, in whom major physiologic disorders such as sleep apnea and nocturnal myoclonus were ruled out, underwent studies of sleep, temperature, motor activity, cognitive performance, and perception of depth of sleep.
Journal of the American Geriatrics SocietyPrevalence and Persistence of Sleep Complaints in a Rural Older Community Sample: The MoVIES Project
163 Citations1996Mary Ganguli, Charles F. Reynolds +1 more
To determine the prevalence and 2‐year persistence of subjective sleep complaints in a rural older population, a large sample of older people in rural areas is studied.
PubMedNew epidemiologic findings about insomnia and its treatment.
155 Citations1992Mitchell B. Balter, E. H. Uhlenhuth
In populations representative of everyday outpatient practice, it was found that the abuse liability of benzodiazepine hypnotics with shorter and longer elimination half-lives was generally low and comparable; and past-year prevalence rates for serious accidents/injuries were much higher for chronic untreated insomnia than for normal controls and most groups treated with psychotherapeutic medications.
Archives of General PsychiatryTreating Psychophysiologic Insomnia With Biofeedback
147 Citations1981Peter Hauri
Insomniacs treated with the biofeedback that seemed appropriate for their specific deficiencies showed significant sleep improvements, while those who received inappropriate feedback did not.
Biological PsychiatryDaytime alertness in subjective and objective insomnia: Some preliminary findings
134 Citations1985Jeffrey L. Sugerman, John A. Stern +1 more
Daytime performance and alertness were examined in two groups of patients with disorders of initiating and maintaining sleep (DIMS) and a control group of self-described good sleepers, and the subjective DIMS group demonstrated an atypical daytime alertness and a tendency toward lowered arousal during vigilance task performance.
Sleep Hygiene, Relaxation Therapy, and Cognitive Interventions
124 Citations1991Peter Hauri
Sleep hygiene, relaxation therapy, and some cognitive interventions make a good package that can often be administered conjointly with chronic insomniacs.
PubMedNonpharmacologic treatments of insomnia.
112 Citations1992Richard R. Bootzin, Michael L. Perlis
Nonpharmacologic treatments that have been evaluated for insomnia are reviewed and direct comparisons between treatments have shown stimulus control instructions to be more effective than either relaxation training or paradoxical intention.
SLEEPZolpidem in the Treatment of Transient Insomnia: A Double-Blind, Randomized Comparison With Placebo
107 Citations1995Thomas Roth, T Roehrs +1 more
It is demonstrated that zolpidem at 7.5 mg and 10 mg is effective in the treatment of transient insomnia, which may be induced by stress, sleep in unfamiliar surroundings, jet lag and other factors.
American Journal of PsychiatryBiopsychobehavioral correlates of insomnia. IV: Diagnosis based on DSM- III
107 Citations1984Tjiauw-Ling Tan, Joyce D. Kales +3 more
This study confirms that patients with chronic insomnia have a high prevalence of psychopathology and characteristic internalizing patterns of anxiety, depression, obsessive-compulsiveness, phobia, and excessive somatic concerns.
Journal of Clinical PsychopharmacologyComparative Hypnotic Effects of Flurazepam, Triazolam, and Placebo
98 Citations1984Merrill M. Mitler, Wesley F. Seidel +3 more
Daytime testing revealed significantly decreased daytime alertness and decreased performance for flurazepam subjects during weeks 3 to 7, although these effects reverted toward baseline despite continued drug administration, suggesting that the onset of the rebound insomnia depended on the rate of drug washout.
PharmacopsychiatryZolpidem and Rebound Insomnia - A Double-Blind, Controlled Polysomnographic Study in Chronic Insomniac Patients
91 Citations1994Jaime M. Monti, P Attali +4 more
It is found that, even after long-term treatment, zol pidem does not induce rebound insomnia or daytime anxiety, and subjective feelings of patients, which were assessed by means of visual analog scales, correlated with polysomnographic data.
SLEEPLongitudinal Changes in Diary- and Laboratory-Based Sleep Measures in Healthy “Old Old” and “Young Old” Subjects: A Three-Year Follow-Up
87 Citations1997Carolyn C. Hoch, Mary Amanda Dew +8 more
Intervention designed to slow age-dependent decreases in sleep quality, continuity, and depth is discussed; sleep would probably deteriorate earlier and more quickly in elderly with more serious health problems and heavier medication use.
SLEEPLong-term Follow-up of Chronic Insomnia
82 Citations1995Wallace B. Mendelson
There was a significant rate of increase in the use of over-the-counter hypnotics at the time of the second follow-up, although there was a low rate of satisfaction associated with them.
Acta Psychiatrica ScandinavicaMental comorbidity of chronic insomnia in general practice attenders using DSM‐III‐R
76 Citations1995Elisabeth Schramm, Fritz Hohagen +3 more
Analysis of links between chronic insomnia and mental and personality disorders using the DSM‐III‐R classification confirmed strong associations between mental disorders and psychopathology.
European Archives of Psychiatry and Clinical NeuroscienceThe zurich study
53 Citations1989Jules Angst, Margarete Vollrath +2 more
The prevalence of sleep problems is stable from age 21–28, at 36%–40%, and the majority of insomniacs cope with sleep problems in various other ways.
Military MedicineGood and Poor Sleepers Differ in Navy Performance
52 Citations1983Laverne C. Johnson, Cheryl L. Spinweber
International Clinical PsychopharmacologyZopiclone improves sleep quality and daytime well-being in insomniac patients
51 Citations1994Göran Hajak, P. Clarenbach +3 more
Daytime well-being was particularly responsive to zopiclone and most responsive in severe insomniacs and with the exception of those to triazolam, rates of response were most pronounced in patients with insomnia of a short duration than in those with insomnia with a longer duration.
PubMedTricyclic antidepressants in the treatment of insomnia.
51 Citations1983J C Ware
The use of tricyclic antidepressants as opposed to hypnotics in treating insomnia is reviewed and TCAs share many of the problems reported for hypnotics, as well as having some potentially serious side effects not present with benzodiazepines.
The Journal of Clinical PharmacologyAlprazolam: Effects on Sleep and Withdrawal Phenomena
46 Citations1987Anthony Kales, Edward O. Bixler +3 more
The clinical utility of alprazolam when administered to insomniac patients appears to be limited because of a relatively rapid development of tolerance and possible disinhibitory reactions during drug use and the occurrence of rebound insomnia following withdrawal.
The Journal of Clinical PharmacologyEstazolam and Flurazepam: A Multicenter, Placebo‐Controlled Comparative Study in Outpatients with Insomnia
45 Citations1990Martin B. Scharf, Paul B Roth +2 more
Estazolam and flurazepam effectively, and comparably, relieved insomnia when administered for 7 nights in adult patients complaining of insomnia.
Journal of Clinical PsychopharmacologySleep Evaluation in Chronic Insomniacs during 14-Day Use
40 Citations1990Daniel F. Kripke, Peter Hauri +2 more
The sleep of patients taking flurazepam 30 mg did not differ significantly from the sleep of those receiving the 15 mg dose for any of the five major sleep variables at any interval, and Objective EEG and subjective PSQ sleep variables showed significant positive correlations.
PsychopharmacologyEffects of zolpidem and flunitrazepam on nocturnal sleep of women subjectively complaining of insomnia
34 Citations1992A.C. Declerck, Frank Ruwe +2 more
European PsychiatryDefining benzodiazepine dependence: the confusion persists
32 Citations1995S. M. Linsen, FG Zitman +1 more
It is concluded that the discussion on the risk of BZD dependence would be well-served by attempting to improve consensus first, which may lead to more meaningful data on the incidence, prevalence and relevant co-factors of BzD dependence.
Journal of International Medical ResearchPilot Controlled Double-Blind Study of the Hypnotic Effects of Zolpidem in Patients with Chronic ‘Learned’ Insomnia: Psychometric and Polysomnographic Evaluation
32 Citations1993W.M. Herrmann, S Kubicki +4 more
The present pilot study justifies a prospective confirmatory comparison of Zolpidem with benzodiazepines in an adequate number of patients and withdrawal after 6–8 weeks of treatment.
International PharmacopsychiatryEfficacy and Side Effects of Lorazepam, Oxazepam, andTemazepam as Sleeping Aids in Psychogeriatric Inpatients
32 Citations2017Markku Linnoila, M Viukari +2 more
All of these short half-life benzodiazepines proved efficacious in maintaining sleep, but none of them reduced initial sleep latency and both lorazepam and oxazEPam had muscle relaxant side effects after awakening.
International Clinical PsychopharmacologyZopiclone versus Flurazepam in Insomnia
31 Citations1990R Élie, GERMAIN LAVOIE +2 more
The results of the study suggest that zopiclone 7·5 mg was at least as potent as flurazepam 30 mg in inducing and maintaining sleep and flurzepam impaired psychomotor coordination whereas zopic lone did not demonstrate daytime protracted effects on psycho-motor performance.
SLEEPHow “Blind” Are Double-Blind Placebo-Controlled Trials of Benzodiazepine Hypnotics?
31 Citations1995Charles M. Morin, Cheryl Colecchi +4 more
Patients who had used hypnotic drugs prior to this trial were more accurate in their judgments of treatment conditions than those without prior exposure, raising an important issue about the internal validity of the double-blind strategy.
PubMedA comparison of the efficacy, tolerance and residual effects of zopiclone, flurazepam and placebo in insomniac outpatients.
27 Citations1990Emanuel Ponciano, FLAVIO M. DE FREITAS +4 more
The lack of residual effects with zopiclone 7.5 mg, at a dose shown to be clinically effective, suggests its use in ambulant or out-patient populations where daytime sedation could interfere with every day activities.
PubMedTrends in the pharmacologic treatment of insomnia.
23 Citations1992James K. Walsh, Christin L. Engelhardt
Data from the National Disease and Therapeutic Index for the time period 1987-1991 (IMS, America) were examined for recent trends in the pharmacologic treatment of insomnia.
Journal of Psychoactive DrugsTreating Insomnia: Pharmacological and Nonpharmacological Approaches
22 Citations1991Donald L. Bliwise
Benzodiazepines are preferred over antidepressants in the treatment of insomnia in individuals without major psychiatric disorder because of fewer side effects and a larger margin of safety.
The Journal of Clinical PharmacologyHypnotic Efficacy of Estazolam Compared with Flurazepam in Outpatients with Insomnia
22 Citations1991Jay B. Cohn, Charles S. Wilcox +2 more
Estazolam 2 mg was found to be as effective a hypnotic as flurazepam 30 mg and is also effective in the treatment of outpatients with insomnia, but to a lesser degree.
British Journal of Clinical PharmacologyDOUBLE‐BLIND EVALUATION OF THE EFFICACY AND SAFETY OF TEMAZEPAM IN OUTPATIENTS WITH INSOMNIA
21 Citations1979John M. Fillingim
Temazepam and glutethimide were rated by the patients as effective and significantly superior to placebo for general quality of sleep, time required to fall asleep, frequency of nocturnal and early morning awakenings, and duration of sleep.
PubMedQuazepam in the short-term treatment of insomnia in outpatients.
20 Citations1983Gary C. Aden, Craig D. Thatcher
Overall, quazepam 30 mg was a safe and effective hypnotic, with significant hypnotic activity on the first night of administration.
PubMedComparative study of lormetazepam and flurazepam in the treatment of insomnia.
18 Citations1984A J Melo de Paula
Results showed that the active drugs were efficient in controlling insomnia, and in some subjective parameters, only 2 mg of lormetazepam was significantly better than placebo.
Journal of Clinical PsychopharmacologyDiazepam
16 Citations1988Anthony Kales, Constantin R. Soldatos +3 more
Findings for the short-term administration and withdrawal of diazepam contrast with those for rapidly eliminated benzodiazepine drugs, which are characterized by a rapid development of tolerance and more frequent and intense withdrawal sleep disturbances.
PubMedDouble-blind crossover comparison of triazolam and lorazepam in the posthypnotic state.
13 Citations1984Cohn Jb
The two active drugs were similar in hypnotic effect and superior to placebo and the most common side effects--drowsiness, lightheadedness, restlessness, impaired coordination, dizziness, and nausea--were reported three times as often with lorazepam than with triazolam or placebo.
Journal of International Medical ResearchShort-Term Study of Quazepam 15 Milligrams in the Treatment of Insomnia
13 Citations1983Raul Hernandez Lara, Pedro Leal Del Rosal +1 more
The hypnotic efficacy and safety of quazepam 15 mg was compared with placebo in thirty-six out-patients with insomnia and was proved to be safe, with no reports of unexpected or serious adverse experiences.
PubMedComparative efficacy of estazolam, flurazepam, and placebo in outpatients with insomnia.
12 Citations1986Roberto A. Dominguez, Burton J. Goldstein +2 more
The efficacy and safety of estazolam, an investigational triazolobenzodiazepine, and flurazepam were compared in 65 insomniac outpatients and global evaluations demonstrated that both treatments were significantly superior to placebo.
PubMedMulti-clinic double-blind comparison of triazolam (Halcion) and placebo administered for 14 consecutive nights in outpatients with insomnia.
12 Citations1978Fabre Lf, J. Brachfeld +4 more
Analysis of pooled efficacy data showed that triazolam was significantly better than placebo on all efficacy parameters measured, including how much the medication helped the patients sleep, onset of sleep, duration ofSleep, duration compared to usual, number of nocturnal awakenings, and feeling of restfulness in the morning.
Journal of International Medical ResearchEvaluation of the Short-Term Treatment of Insomnia in Out-Patients with 15 Milligrams of Quazepam
10 Citations1983Joseph Mendels, Stephen L. Stern
It is demonstrated that quazepam, in a 15 mg dose, is an effective, rapidly acting, oral hypnotic agent with a low incidence of adverse effects.
SLEEPEligibility Requirements in Hypnotic Trials
9 Citations1985Timothy Roehrs, G Vogel +6 more
The data show that the statistical phenomenon of regression toward the mean must be considered in designing hypnotic efficacy studies, and that the systematic difference between laboratories, change in procedure, or systematic loss of patients from screen 1 to 2 is unacceptable.
PubMedA dose-range finding study of zopiclone in insomniac patients.
9 Citations1990N.P.V. Nair, Gary E. Schwartz +3 more
Clinicians' global impressions showed that the severity of illness clearly decreased in a dose related manner up to zopiclone 11.25 mg, which favours the use of 7.5 mg zopicLone as the optimum dose for most patients, although certain patients may benefit from a higher dose of the drug when well tolerated.
PubMedTreatment of insomnia with temazepam: double-blind, placebo-controlled evaluation.
9 Citations1982Cuanang, L Limos
Patients who took 10 or 20 mg of temazepam slept better than those who took placebo on the first three nights of taking the hypnotic, and there was a significant reduction in the time of onset of sleep, and the duration of sleep.
Fortschritte der Neurologie · PsychiatrieSchlafstörungen - Was tun, wenn Schlafmittel nicht mehr helfen?
5 Citations1995J. Staedt, Gabriela Stoppe +3 more
A therapeutic regimen is demonstrated which allows a step-by-step replacement of hypnotics by sedative antidepressants, which reduces on the one hand the risk of developing a severe withdrawal syndrome and on the other hand improves insomnia and insomnia-associated depressive symptoms.
PubMedPsychiatric management of sleep disorders.
3 Citations1991Jamie K. Lilie, Henry W. Lahmeyer
This chapter will focus on the office management of psychiatric patients with sleep disorders with psychiatric aspects of insomnia, the parasomnias, circadian rhythm disorder and disorders of excessive sleepiness.